| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908751 | Leukemia Research | 2014 | 9 Pages |
Abstract
Future steps in the clinical development of oral inhibitors include the optimization of the schedule and the definition of their antitumor activity in MM.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alessandro Allegra, Andrea Alonci, Demetrio Gerace, Sabina Russo, Vanessa Innao, Laura Calabrò, Caterina Musolino,